Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS)

80 filings reported holding CLLS - Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share as of Q4 2021.
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 15.2M shares of 95.5M outstanding shares and own 15.91% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (2.94M shares), Capital International Investors (1.59M shares), PRINCIPAL FINANCIAL GROUP INC (1.23M shares), CREDIT SUISSE AG/ (1.2M shares), Long Focus Capital Management, LLC (1.16M shares), BAILLIE GIFFORD & CO (1.08M shares), Capital World Investors (875K shares), Sumitomo Mitsui Trust Holdings, Inc. (628K shares), Nikko Asset Management Americas, Inc. (628K shares), and Bpifrance SA (426K shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.